← back to search

Andrew L. Clark

University of Bedfordshire · GB
Area of research
Cardiology and Cardiovascular Medicine · Complementary and alternative medicine
Research interest
Research interests include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac pacing and defibrillation studies, and Cardiovascular and exercise physiology.
h-index
73
citations
23,104
works
719
NIH funding
primary concept
Medicine
email

Recent publications

Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial
Cardiovascular Diabetology 2025cited by 11position: middledoi
Health inequalities and trends in heart failure diagnosis in primary care in England, 2000–21: a national retrospective cohort data-linkage study
The Lancet Primary Care 2025cited by 5position: middledoi
Heart Failure Specialist Care and Long-Term Outcomes for Patients Admitted With Acute Heart Failure
JACC Heart Failure 2024cited by 25position: middledoi
Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey
BMJ Public Health 2024cited by 8position: middledoi
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
Circulation Heart Failure 2023cited by 31position: middledoi
Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)
The American Journal of Cardiology 2023cited by 2position: middledoi
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
New England Journal of Medicine 2022cited by 535position: middledoi
Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the <scp>SilHF</scp> study): a randomized placebo‐controlled multicentre trial
European Journal of Heart Failure 2022cited by 41position: middledoi
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the <scp>HOMAGE</scp> trial
European Journal of Heart Failure 2022cited by 13position: middledoi
Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from <scp>HOMAGE</scp> and the <scp>UK</scp> Biobank
European Journal of Heart Failure 2022cited by 12position: middledoi
Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial
Clinical Research in Cardiology 2022cited by 11position: middledoi
Dyskalemia in People at Increased Risk for Heart Failure: Findings from the Heart ‘OMics’ in AGEing (HOMAGE) Trial
ESC Heart Failure 2022cited by 7position: middledoi
Urinary peptides in heart failure: a link to molecular pathophysiology
European Journal of Heart Failure 2021cited by 62position: middledoi
Identification of Sex-Specific Biomarkers Predicting New-Onset Heart Failure
ESC Heart Failure 2021cited by 17position: middledoi
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial
European Heart Journal - Cardiovascular Pharmacotherapy 2021cited by 16position: middledoi
Change in renal function associated with drug treatment in heart failure: national guidance
Heart 2019cited by 96position: firstdoi
Prevalence and Prognostic Significance of Malnutrition Using 3 Scoring Systems Among Outpatients With Heart Failure
JACC Heart Failure 2018cited by 319position: lastdoi
Hypertension, Training
2012cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John G.F. Cleland · Wythenshawe Hospital11 papers (2018–2025)Pierpaolo Pellicori · University of Glasgow9 papers (2018–2025)Nicolas Girerd · Inserm8 papers (2021–2025)Patrick Rossignol · Centre d'Investigation Clinique Pierre Drouin8 papers (2021–2025)Stéphane Heymans · Maastricht University Medical Centre8 papers (2021–2025)João Pedro Ferreira · Institut des Sciences et technologies pour une Economie Circulaire des énergies bas carbone7 papers (2021–2025)Job A.J. Verdonschot · Anna Needs Neuroblastoma Answers7 papers (2021–2025)Jan A. Staessen · State Key Laboratory of Medical Genomics7 papers (2021–2023)Timothy Collier · University of London7 papers (2021–2023)Johannes Petutschnigg · Humboldt-Universität zu Berlin6 papers (2021–2025)Faı̈ez Zannad · Université de Caen Normandie6 papers (2021–2023)Mark R. Hazebroek · Maastricht University6 papers (2021–2023)Arantxa González · Instituto de Salud Carlos III5 papers (2021–2025)Christian Delles · University of Glasgow3 papers (2021–2025)Franco Cosmi · Società Italiana di Cardiologia3 papers (2021–2022)Frank Edelmann · Sequoia (United States)3 papers (2021–2025)Mark C. Petrie · King's College London3 papers (2019–2025)Beatrice Mariottoni · Fondazione Andrea Cesalpino3 papers (2021–2022)Fozia Ahmed · Keele University2 papers (2021–2022)Joe Cuthbert · Hull and East Yorkshire Hospitals NHS Trust2 papers (2021–2022)